[an error occurred while processing this directive]
State Key Laboratory of Phytochemisty and Plant Resources in Southwest China
CHENG Yongxian's Group
CHEN Jijun's Group
HAO Xiaojiang's Group
LIU Jikai's Group
LUO Xiaodong's Group
QIU Minghua's Group
ZENG Ying's Group
SUN Handong's Group
TAN Ninghua's Group
ZHANG Yingjun's Group
ZHAO Qinshi's Group
LUO Huairong's Group
LI Yan's Group
LI Shenghong's Group
YANG Yurong's Group
XIA Chengfeng's Group
ZHAO Jinhua's Group
QIN Hongbo's Group
WU Bin's Group
XU Gang's Group
ZHOU Jun's Group
LIU Haiyang's Group
XIONG Wenyong's Group
HU Kaifeng's Group
Location: Home > Our Groups > State Key Laboratory of Phytochemisty and Plant Resources in Southwest China > CHENG Yongxian's Group > Major Research Achievements
Major Research Achievements

Our research field is traditional Chinese medicine. We try to understand WHAT substances are responsible for the function and therapeutic indications of TCM and HOW they work alone or together. Generally, we are curious about any TCM which is most impressed on their distinct efficacy in clinical practice. Actually, our favorite direction is chronic renal diseases including diabetic nephropathy and organ fibrosis, brain-related disorders including anxiety, learning and memory. From 2007 to present, we have studied more than 30 TCM species, around 2000 compounds were isolated and characterized. Oriented screening led to the discovery of several active substances. We have a small team but published 54 papers, and 38 of them are seen in international journals. We have also applied 20 domestic patents. Among the active compounds, one NMDA receptor antagonist supported by the 12th five-year plan from National Ministry of Science and Technology, one smad3 selective inhibitor and one cell cycle inhibitor for the treatment of cancer is entering into drug delopment.

[an error occurred while processing this directive]